Comparison of Screening Tests in Detecting Cervical Neoplasia
Primary Purpose
Cervical Cancer
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Papanicolaou test
cytology specimen collection procedure
annual screening
colposcopic biopsy
comparison of screening methods
Sponsored by
About this trial
This is an interventional screening trial for Cervical Cancer focused on measuring cervical cancer
Eligibility Criteria
Inclusion Criteria:: History of cervical neoplasia Presenting for a well-woman visit, annual Pap smear, or family planning Other gynecological or non-gynecological complaints allowed OR Referred for colposcopy secondary to an abnormal Pap smear Planned screening for cervical cancer Over 18 years of age Prior laser surgery, cryotherapy, or conization or loop electrosurgical excision procedure for cervical neoplasia allowed Exclusion Criteria: bleeding diathesis pregnant prior hysterectomy concurrent anticoagulants
Sites / Locations
- Jonsson Comprehensive Cancer Center, UCLA
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
NCT ID
NCT00039312
First Posted
June 6, 2002
Last Updated
July 30, 2020
Sponsor
Jonsson Comprehensive Cancer Center
1. Study Identification
Unique Protocol Identification Number
NCT00039312
Brief Title
Comparison of Screening Tests in Detecting Cervical Neoplasia
Official Title
Multi-Institutional Prospective Cohort Study For The Comparison Of Different Primary Screening Strategies For The Detection Of Cervical Neoplasia
Study Type
Interventional
2. Study Status
Record Verification Date
July 2012
Overall Recruitment Status
Completed
Study Start Date
December 1999 (undefined)
Primary Completion Date
August 2003 (Actual)
Study Completion Date
April 2010 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Jonsson Comprehensive Cancer Center
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
RATIONALE: Screening tests may help doctors detect abnormal cells in the cervix early and plan effective treatment.
PURPOSE: Screening trial to compare different types of screening tests used to detect cervical neoplasia.
Detailed Description
OBJECTIVES:
Compare the sensitivity and specificity of primary screening strategies for the detection of cervical intraepithelial or invasive neoplasia.
Compare the positive and negative predictive values of these strategies.
OUTLINE: This is a multicenter study. Patients are stratified according to the reason for the visit (general gynecological screening vs colposcopy referral).
Stratum 1 (general gynecological screening): Patients undergo Pap smear, visual inspection aided by acetic acid (VIA), a colposcopy, and finally a visual inspection aided by toluidine blue (VIT) followed by an acetic acid wash. A biopsy may be performed at this initial visit. Within 2-3 weeks, patients are notified of results.
Stratum 2 (colposcopy referral): Patients undergo Pap smear, VIA, colposcopy, VIT, and possible biopsy as in stratum 1. During the same visit, patients receive histologic evaluation and treatment with See-and-Treat loop electrosurgical excision procedure and/or endocervical curettage.
PROJECTED ACCRUAL: A total of 600-1,000 patients (300-500 per stratum) will be accrued for this study.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cervical Cancer
Keywords
cervical cancer
7. Study Design
Primary Purpose
Screening
Study Phase
Not Applicable
Enrollment
15 (Actual)
8. Arms, Groups, and Interventions
Intervention Type
Other
Intervention Name(s)
Papanicolaou test
Intervention Type
Other
Intervention Name(s)
cytology specimen collection procedure
Intervention Type
Procedure
Intervention Name(s)
annual screening
Intervention Type
Procedure
Intervention Name(s)
colposcopic biopsy
Intervention Type
Procedure
Intervention Name(s)
comparison of screening methods
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria::
History of cervical neoplasia
Presenting for a well-woman visit, annual Pap smear, or family planning
Other gynecological or non-gynecological complaints allowed OR
Referred for colposcopy secondary to an abnormal Pap smear
Planned screening for cervical cancer
Over 18 years of age
Prior laser surgery, cryotherapy, or conization or loop electrosurgical excision procedure for cervical neoplasia allowed
Exclusion Criteria:
bleeding diathesis
pregnant
prior hysterectomy
concurrent anticoagulants
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christine Holschneider, MD
Organizational Affiliation
Jonsson Comprehensive Cancer Center
Official's Role
Study Chair
Facility Information:
Facility Name
Jonsson Comprehensive Cancer Center, UCLA
City
Los Angeles
State/Province
California
ZIP/Postal Code
90095-1781
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Comparison of Screening Tests in Detecting Cervical Neoplasia
We'll reach out to this number within 24 hrs